ESC 365 - Worsening pulmonary arterial hypertension in hereditary hemorrhagic telangiectasia following bevacizumab therapy

ESC2025 Premium Access

Worsening pulmonary arterial hypertension in hereditary hemorrhagic telangiectasia following bevacizumab therapy

Session: Challenges in cardio-oncology (2)

Topic: Clinical

Speaker: Doctor H. Triantafyllidi (Athens, GR)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Doctor Helen Triantafyllidi

Attikon University Hospital, Athens (Greece)

2 presentations

0 follower

3 more presentations in this session

Arsenic trioxide-induced non-sustained monomorphic ventricular tachycardia without QT prolongation in acute promyelocytic leukemia

Speaker: Doctor A. Wasir (Pune, IN)

A rare case of fulminant talquetamab-induced myocarditis presenting as an acute ST-segment elevation myocardial infarction

Speaker: Doctor E. Kim (New York City, US)

A heart under crossfire: the diagnostic challenge of left ventricular dysfunction

Speaker: Doctor S. Andraz (Faro, PT) Doctor L. Hamann (Faro, PT)

Access the full session

Challenges in cardio-oncology (2)

Speakers: Doctor H. Triantafyllidi, Doctor A. Wasir, Doctor E. Kim, Doctor S. Andraz, Doctor L. Hamann

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources